Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 23782140)

1.

Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel--prophylactic effect of antiulcer drugs.

Takeuchi K, Izuhara C, Takayama S, Momode T, Kojo M, Hara D, Amagase K.

Curr Pharm Des. 2014;20(7):1139-48.

PMID:
23782140
2.

A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.

Takayama S, Izuhara C, Yamada N, Yamanaka S, Hashimoto E, Kaneko S, Takeuchi K.

J Physiol Pharmacol. 2012 Feb;63(1):41-52.

3.

Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.

Takeuchi K, Takayama S, Hashimoto E, Itayama M, Amagase K, Izuhara C.

J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:37-46. doi: 10.1111/jgh.12774.

PMID:
25521732
4.

Comparative effects of the anti-platelet drugs, clopidogrel, ticlopidine, and cilostazol on aspirin-induced gastric bleeding and damage in rats.

Takeuchi K, Takayama S, Izuhara C.

Life Sci. 2014 Aug 21;110(2):77-85. doi: 10.1016/j.lfs.2014.06.017. Epub 2014 Jun 28.

PMID:
24984214
5.

Anti-platelet therapy and managing ulcer risk.

Chan FK.

J Gastroenterol Hepatol. 2012 Feb;27(2):195-9. doi: 10.1111/j.1440-1746.2011.07029.x.

PMID:
22142030
6.

New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin.

Nonoyama K, Nakagawa K, Amagase K, Takeuchi K, Nakamura M, Okabe S.

J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S15-22. doi: 10.1111/j.1440-1746.2010.06227.x.

PMID:
20586859
8.

Clopidogrel. Patients with peptic ulcers.

Beales IL.

BMJ. 2009 May 20;338:b1932. doi: 10.1136/bmj.b1932. No abstract available.

PMID:
19457957
9.

Aspirin-induced gastric ulcers in cats. Prevention by prostacyclin.

Konturek SJ, Radecki T, Brzozowski T, Piastucki I, Zmuda A, Dembińska-Kieć A.

Dig Dis Sci. 1981 Nov;26(11):1003-12.

PMID:
6117433
10.

Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats.

Takeuchi K, Yasuhiro T, Asada Y, Sugawa Y.

Digestion. 1998 Jul-Aug;59(4):298-307.

PMID:
9693199
11.

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ.

N Engl J Med. 2005 Jan 20;352(3):238-44.

12.

Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man.

Konturek SJ, Kwiecień N, Obtułowicz W, Polański M, Kopp B, Oleksy J.

Gut. 1983 Feb;24(2):89-93.

13.

Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.

Zhu LL, Xu LC, Chen Y, Zhou Q, Zeng S.

World J Gastroenterol. 2012 Jun 28;18(24):3167-72. doi: 10.3748/wjg.v18.i24.3167.

14.

[Dilemma between gastroprotection and cardiovascular prevention].

Venerito M, Kandulski A, Malfertheiner P.

Dtsch Med Wochenschr. 2010 Nov;135(44):2193-8. doi: 10.1055/s-0030-1267498. Epub 2010 Oct 26. Review. German.

PMID:
20979006
15.

Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.

Luo JC, Huang KW, Leu HB, Chen LC, Hou MC, Li CP, Lu CL, Lin HC, Lee FY, Lee SD.

Aliment Pharmacol Ther. 2011 Sep;34(5):519-25. doi: 10.1111/j.1365-2036.2011.04760.x. Epub 2011 Jul 5.

PMID:
21726257
16.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
17.

Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.

Iwamoto J, Saito Y, Honda A, Matsuzaki Y.

World J Gastroenterol. 2013 Mar 21;19(11):1673-82. doi: 10.3748/wjg.v19.i11.1673. Review.

18.

Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.

Uotani T, Sugimoto M, Nishino M, Ichikawa H, Sahara S, Yamade M, Iwaizumi M, Yamada T, Osawa S, Sugimoto K, Umemura K, Watanabe H, Miyajima H, Furuta T.

J Clin Pharmacol. 2014 Aug;54(8):858-64. doi: 10.1002/jcph.284. Epub 2014 Mar 21.

PMID:
24615745
19.

Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E.

CMAJ. 2011 Nov 8;183(16):1835-43. doi: 10.1503/cmaj.100912. Epub 2011 Sep 26.

20.

Ticlopidine prevents the formation but delays the healing of ethanol-induced gastric lesions in the rat.

Sibilia V, Pagani F, Lattuada N, De Luca V, Guidobono F, Soglian A, Netti C.

Pharmacol Res. 2007 May;55(5):418-25. Epub 2007 Feb 2.

PMID:
17324584
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk